A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Vertex Pharmaceuticals (NASDAQ: VRTX) and Mirum Pharmaceuticals (NASDAQ: MIRM) are two biotech stocks that share the same ...
Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, ...
The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...
Researchers developed a gorilla adenovirus platform with inherent tumor selectivity, lung tropism, and large-gene capacity.
Gas prices have soared roughly 80% year to date. When transportation costs rise, so do the prices of most products. Federal ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
Phage therapy is emerging as a potential solution to antibiotic resistance and superbugs, with clinical advances in ...
What started as a late-40s idea that most biotech experts would have called impossible is now a $7.9 billion company. Built ...
Bhopal (Madhya Pradesh): Despite having super-speciality facilities, no government medical college in the state has taken the ...
Dalin Hatch didn't expect he'd walk the halls of a hospital for his career. The soon-to-be college graduate already works as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results